So Tiffany Y, Mitchell Peter J, Dowling Richard J, Yan Bernard
Department of Neurology, The Royal Melbourne Hospital, Parkville, Victoria, Australia; Department of Radiology, The Royal Melbourne Hospital, Parkville, Victoria, Australia.
Department of Radiology, The Royal Melbourne Hospital, Parkville, Victoria, Australia.
Clin Neurol Neurosurg. 2014 Feb;117:6-11. doi: 10.1016/j.clineuro.2013.11.015. Epub 2013 Dec 1.
Intracranial intradural dissections are challenging to treat, and published data regarding treatment outcomes remains relatively limited. We retrospectively evaluated our experience with endovascular techniques in the treatment of intracranial intradural dissections, and describe the efficacy and clinical outcomes with treatment.
Between January 2003 and December 2011, 23 patients with 23 intracranial intradural arterial dissections underwent endovascular treatment at our institution. Eighteen were treated with coil embolization (14 with parent vessel sacrifice, 4 with aneurysm coiling), 4 with flow diverting stents (Pipeline Embolization Device) and 1 with primary angioplasty and stenting. Treatment indications were subarachnoid hemorrhage (n=16), cerebral ischemia (n=2), headache (n=3), or elective (n=2).
The peri-procedural complication rate was 17.4%, 3 of the 4 cases sustained no serious clinical sequelae. Four deaths unrelated to the procedure occurred in patients with subarachnoid hemorrhage. Angiographic follow-up demonstrated complete occlusion in 8 of 14 surviving cases treated by coil embolization, incomplete occlusion in 2 cases. Four cases were lost to follow-up, but all of these had complete occlusion post-procedure. Successful angiographic outcomes were seen at follow-up in patients treated with flow diverting stents and primary intracranial stenting. Clinical follow-up showed a mRS of 0-1 in 15 (78.9%) of 19 patients, mRS of 2 in 1 patient, mRS of 3 in 1 patient and mRS of 5 in 1 patient. There was no neurological deterioration, re-bleeding or deaths during the follow-up period.
Intracranial arterial dissections, particularly those presenting with subarachnoid hemorrhage, are lesions associated with high mortality. They can be effectively managed endovascularly. In our experience, endovascular treatment can be associated with moderate peri-procedural risks.
颅内硬脑膜内夹层动脉瘤的治疗具有挑战性,关于治疗结果的已发表数据仍然相对有限。我们回顾性评估了我们在颅内硬脑膜内夹层动脉瘤治疗中使用血管内技术的经验,并描述了治疗的疗效和临床结果。
2003年1月至2011年12月期间,23例患有23个颅内硬脑膜内动脉夹层动脉瘤的患者在我们机构接受了血管内治疗。18例接受弹簧圈栓塞治疗(14例牺牲载瘤动脉,4例进行动脉瘤弹簧圈栓塞),4例接受血流导向支架(Pipeline栓塞装置)治疗,1例接受初次血管成形术和支架置入术。治疗指征为蛛网膜下腔出血(n = 16)、脑缺血(n = 2)、头痛(n = 3)或择期治疗(n = 2)。
围手术期并发症发生率为17.4%,4例中有3例未出现严重临床后遗症。蛛网膜下腔出血患者中有4例与手术无关的死亡。血管造影随访显示,14例接受弹簧圈栓塞治疗的存活病例中有8例完全闭塞,2例不完全闭塞。4例失访,但所有这些病例术后均完全闭塞。接受血流导向支架和初次颅内支架置入术治疗的患者在随访时血管造影结果成功。临床随访显示,19例患者中有15例(78.9%)改良Rankin量表(mRS)评分为0 - 1分,1例为2分,1例为3分,1例为5分。随访期间无神经功能恶化、再出血或死亡。
颅内动脉夹层动脉瘤,尤其是那些表现为蛛网膜下腔出血的病变,是死亡率较高的疾病。它们可以通过血管内有效地治疗。根据我们的经验,血管内治疗可能与中度围手术期风险相关。